n
 
About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Monday, March 19th, 2018

The QualityStocks
Daily Stock List

graphic
graphic

Delta International Oil & Gas, Inc. (DLTZ)

OTC Markets, Speculating Stocks, and MarketWatch reported on Delta International Oil & Gas, Inc. (DLTZ), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Delta International Oil & Gas, Inc. is an international, independent oil and gas company specializing in energy. Until recently, its main concentration was on oil and gas exploration in northern Argentina via its subsidiary SAHF, LLC. In 2017, upon an evaluation of the U.S. domestic E&P market, it decided to focus its investments locally.

Delta International Oil & Gas is headquartered in Scottsdale, Arizona. The Company previously went by the name Delta Mutual, Inc. It changed its name to Delta International Oil & Gas Inc. in October of 2013. The Company’s shares trade on the OTC Markets’ OTCQB.

The Company’s investment in MHD Technology Corp. helps extend its reach in the energy field. MHD Technology is a New York company that works to apply its patented technology in MagnetoHydroDynamics to water pipelines in the continental U.S.

Delta International Oil & Gas is evaluating prospects for investments in fields other than oil and gas exploration and production. The Company previously announced its acquisition of a 10 percent interest in MHD Technology Corp. by way of its wholly-owned subsidiary Neptune Industries LLC.

MHD Technology is developing an inventive water transportation and desalination technology. MHD's next steps are to perform a simulation of its product and then to make the initial prototype. Delta's subsidiary, Neptune Industries, will initially be involved in both steps, as well as in some administrative capacity.

As of March 31, 2016, Delta International Oil & Gas, via South American Hedge Fund LLC (SAHF), retained 18 percent of the total concession in the carryover mode (no cost obligations to SAHF) in the Tartagal and Morillo oil and gas concessions in Northern Argentina. The Company does not operate the Tartagal and Morillo concession. It has a minority position in the JV.

In addition, Delta holds a 30.6 percent interest in the Valle de Lerma concession in Northern Argentina. The JV partners are Grasta SA, PetroNEXUS, High Luck Group, and REMSA.

The properties presently held by SAHF are Tartagal Oriental, Morillo, and Valle de Lerma. SAHF is in the process of selling the Tartagal Oriental and Morillo properties. SAHF is not owned by Delta anymore, but as the sale of Tartagal Oriental and Morillo closes, Delta will receive 75 percent of the revenues generated by the transaction. This includes royalties on the production of the properties.

Delta signed an agreement with High Luck for the sale of 18 percent of Tartagal and Morillo. Moreover, the Company signed and executed an agreement for the transfer of 100 percent of its interest in SAHF.

In September of 2017, Delta International Oil & Gas announced that it signed an asset purchase agreement for the acquisition of an oil property in Polk County, Texas from Crestmont Operating, LLC. With the definitive agreement, the Company acquired a 4-well lease in Polk County, estimated to produce 15-20 barrels of oil per day once a workover is completed on one of the wells.

Delta’s domestic oil and gas acquisition strategy commenced in Q2 2017 with a debt/equity investment in a business that is performing rework on gas wells in California. Additionally, it is looking at other opportunities in Texas, Oklahoma, and California to continue its strategy execution.

Furthermore, the Company is prospecting its entry into the water sector. In 2016, it made an initial investment into a water propulsion company.

Delta International Oil & Gas, Inc. (DLTZ), closed Monday's trading session at $0.19, up 18.75%, on 529,691 volume with 131 trades. The average volume for the last 60 days is 28,413 and the stock's 52-week low/high is $0.0155/$0.19.

NXT Energy Solutions, Inc. (NSFDF)

Serious Traders, SmarTrend Newsletters, Vantage Wire, StockOoodles, and Streetwise Reports reported beforehand on NXT Energy Solutions, Inc. (NSFDF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, NXT Energy Solutions, Inc. is a technology enterprise formed in 1994. Its proprietary Stress Field Detection (SFD®) survey system uses quantum-scale sensors to detect gravity field perturbations in an airborne survey method, which can be used onshore and offshore to remotely identify areas with exploration potential for traps and reservoirs. NXT Energy Solutions is headquartered in Calgary, Alberta.

NXT serves customers through direct sales methods and commissioned sales representatives, chiefly in North America. The Company provides its clients with an effective and reliable method to reduce time, costs, and also risks related to exploration.

The SFD® survey system enables its clients to focus their hydrocarbon exploration decisions concerning land commitments, data acquisition expenditures, and prospect prioritization on areas with the greatest potential. SFD® is environmentally friendly. It is unaffected by ground security issues or difficult terrain. NXT Energy Solutions’ unique geophysical service is for the upstream oil & gas industry.

SFD® is an airborne tool; provides information on areas favorable to fluid entrapment in the sedimentary column. The SFD® survey is complementary to existing geophysical methods, especially seismic programs.

In pre-seismic applications, SFD® can produce high-potential prospect leads in large underexplored regions. In post-seismic applications, SFD® can prioritize seismic prospects based on their reservoir potentials.

In January 0f 2017, NXT Energy Solutions announced the first international patent of the Stress Field Detection (SFD®) Technology and the development of a new generation of sensors, which will enhance NXT’s ability to provide higher quality survey results.

The Company’s patented SFD® Technology was previously approved by the Comisión Nacional de Hidrocarburos, (CNH), for work credits by exploration companies in Mexico. The airborne survey was to be conducted over the areas that have been identified by CNH for the shallow water bid-round 2.1, covering the Tampico-Misantla, Veracruz, and Cuencas del Sureste exploration areas.

Last month, NXT Energy Solutions announced that it entered into an agreement to complete a three-tranche private placement under which Alberta Green Ventures Limited Partnership committed to buy 10,905,212 units of the Corporation at a price of $0.924 per Unit for total gross proceeds of roughly $10,076,416.

The net proceeds of this issue will provide NXT Energy Solutions with funds to pursue, close, and implement commercial transactions now in negotiation. It will also provide the Company funds to develop additional revenue streams (including multi-client data sales and strategic partnerships) as well as funds for general corporate and working capital purposes.

NXT is actively negotiating commercial contracts for the application of its proprietary SFD® oil & gas exploration method with governments, national oil companies, and other industry participants.

NXT Energy Solutions, Inc. (NSFDF), closed Monday's trading session at $0.96, down 5.79%, on 11,518 volume with 8 trades. The average volume for the last 60 days is 34,382 and the stock's 52-week low/high is $0.317/$1.04.

MassRoots, Inc. (MSRT)

CFN Media Group, Wealth Daily, Cannabis Financial Network News, Equities, The Street, Promotion Stock Secrets, Stock Commander, PennyStockLocks, PennyStockScholar, Profitable Trader Authority, SmallCapVoice, Penny Stock 101, Money Morning, Stock News Now, OTCtipReporter, StockRockandRoll, SeeThruEquity Research, Damn Good Penny Picks, Penny Picks, and OTCJournal reported earlier on MassRoots, Inc. (MSRT), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

MassRoots, Inc. is a foremost technology platform for medical cannabis patients and businesses. Individuals use its application to share their cannabis experiences and stay connected with local dispensaries. MassRoots has affiliations with the top organizations in the cannabis industry. These include the ArcView Group and the National Cannabis Industry Association. OTCQB-listed, MassRoots is based in Denver, Colorado.

Businesses can use MassRoots to advertise their goods and services to cannabis consumers. MassRoots starts adding in features. These include order ahead, delivery, and the in-app purchase of ancillary products as regulations allow. MassRoots has some estimated 300-plus dispensaries actively posting on its network.

The Company’s product pipeline includes Dispensary Finder & Menus; Product Pages & Reviews; Sponsored Posts 2.0; and Enhanced Profiles. Most of the Company’s advertising revenue has come from dispensaries and cannabis-brands in California and Colorado.

MassRoots completed its acquisition of DDDigtal, d.b.a. "Whaxy" in January of 2017. This is an online order-ahead and menu management platform. MassRoots has made a strategic investment in High Times Holding Corporation, "High Times", which is the leading voice of the Cannabis Industry.

MassRoots has acquired Odava, Inc. MassRoots now offers dispensaries a complete set of software to manage their regulatory compliance, streamline their supply chain, and develop successful consumer loyalty programs. Odava is a leading compliance and point-of-sale (POS) system for the cannabis industry.

MassRoots also acquired CannaRegs, Inc. It entered into a definitive agreement to acquire CannaRegs in a stock deal valued at about $12 million. CannaRegs is a top technology platform. It tracks changes in cannabis regulations and taxation at the municipal, state, and federal levels.

MassRoots and New Frontier Data have partnered to elevate digital marketing practices and better understand social consumer behavior at a crucial time in the cannabis industry. New Frontier Data is the foremost provider of data, analytics and business intelligence in the cannabis industry. New Frontier Data's data engine will allow MassRoots to aggregate, analyze, and monetize the large volume of consumer engagement data undergoing collection by the MassRoots mobile application and website.

Recently, MassRoots announced the early-stage testing of a new concierge service for cannabis enthusiasts. This service marks a new partnership with Diem Cannabis, an Oregon-based dispensary and delivery service. Early tests will be available throughout Portland and nearby Salem. These will provide delivery customers with a virtual budtender to help them select the proper order for their particular needs.

MassRoots' new concierge service will enable consumers to speak by phone or text chat with a virtual budtender, ask questions, get recommendations, and verify all information is correct before MassRoots sends the order to Diem. Then, Diem Cannabis will fulfill and deliver the final order to the consumer, accepting payment on delivery.

MassRoots has recently formed MassRoots Blockchain Technologies, Inc. This is a wholly-owned subsidiary of MassRoots dedicated to developing blockchain-based solutions for the cannabis industry.

MassRoots Chief Executive Officer, Isaac Dietrich, said, "We believe blockchain has the potential to enable the cannabis industry to operate more efficiently and with a greater degree of accountability and transparency. MassRoots looks forward to being a pioneer in exploring blockchain-based solutions for the multi-billion dollar cannabis industry."

MassRoots, Inc. (MSRT), closed Monday's trading session at $0.25, even for the day, on 370,873 volume with 169 trades. The average volume for the last 60 days is 2,490,115 and the stock's 52-week low/high is $0.1156/$1.17.

Orbital Tracking Corp. (TRKKD)

Stock Commander, Penny Stock General, Fast Money Alerts, Stock Shock and Awe, Stock Preacher, Beacon Equity Research, SuperStockTips, Penny Stock Finder, Penny Stock Craze, MicroCapDaily, OTCMagic, SmallCap Network, InvestorSoup, and Shiznit Stocks reported previously on Orbital Tracking Corp. (TRKKD), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Orbital Tracking Corp. provides satellite based tracking, services, and mobile voice and data communications services around the world, through satellite, to commercial and government users. In February of 2015, the Company completed a reverse merger and a subsequent $1.1 million equity capital raise. This created Orbital Tracking Corp., a publically listed organization including the operations of Global Telesat Communications Ltd., a UK corporation (GTCL). OTC Bulletin Board-listed, Orbital Tracking is based in Aventura, Florida.

Orbital Tracking operates different e-commerce retail and tracking sites where users around the world can buy satellite hardware and track assets in real-time on mobile devices or personal computers (PCs).

Orbital Tracking (as a newly combined entity) launched as a fully operational Mobile Satellite Solutions (MSS) business. It specializes in services related to the Globalstar satellite constellation. This includes ground station construction, simplex tracking services, and satellite telecommunications voice airtime.

Orbital Tracking’s subsidiaries, U.S.-based Orbital Satcom Corp. and European Union (EU)-based Global Telesat Communications Ltd., provide around the world distribution of a broad spectrum of portable satellite voice, data, and tracking solutions.

Global Telesat Communications (GTC) is a supplier of mobile voice and data communications services via satellite. GTC provides equipment and airtime for use on all the major satellite networks. This includes Globalstar, Inmarsat, Iridium, and Thuraya, permitting users in remote locations to make phone calls, connect to the internet, and track assets or personnel anywhere globally.

Orbital Tracking’s subsidiary, Global Telesat Communications (GTC), announced in January of 2017 that it attained the milestone of selling 10,000 SPOT devices. SPOT LLC, a wholly-owned subsidiary of Globalstar, Inc. is the leader in satellite messaging and emergency notification technologies. GTC's customer base for SPOT encompasses B2B and consumer markets.

This past November, Orbital Tracking reported financial results for the three and nine months ended September 30, 2017. Q3 2017 highlights include Revenues of approximately $1,588,466 versus approximately $1,299,373 of Revenues for the three months ended September 30, 2016. This represents an increase in Total Revenues of $289,093 or 22.3 percent.

Orbital Tracking recorded a Net Loss before Income Tax of approximately $265,699 for the three months ended September 30, 2017 versus a Net Loss of $338,672, for the three months ended September 30, 2016. During Q3 2017, Orbital Tracking continued to report combined Sales at record levels, resulting in three consecutive quarters of increasing revenue growth during 2017, together with a reduction in operating expenses versus the comparable 2016 quarter.

Orbital Tracking Corp. (TRKKD), closed Monday's trading session at $2.50, up 14.16%, on 595 volume with 5 trades. The average volume for the last 60 days is 7,804 and the stock's 52-week low/high is $1.365/$4.485.

Acacia Diversified Holdings, Inc. (ACCA)

Real Pennies, DailyMarijuanaObserver, and InvestorsHub reported previously on Acacia Diversified Holdings, Inc. (ACCA), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Acacia Diversified Holdings, Inc. is an emerging cannabis business listed on the OTC Markets’ OTCQB. The Company’s wholly-owned subsidiaries are MariJ Pharmaceuticals, Inc. (MariJ) and Canna-Cures Research & Development Center, Inc. (Canna-Cures). By way of these, Acacia focuses on the development of new and proprietary medicinal products for patients - with USDA certified organic mobile processing and handling solutions for its customers. Acacia Diversified Holdings is based in Clearwater, Florida.

MariJ Pharmaceuticals’ concentration is on the extraction and processing of very high quality, high-CBD/low-THC content medical grade cannabis oils from medical cannabis plants. MariJ specializes in organic strains of the plant. This sets itself apart from the general producers of non-organic products.

In addition, MariJ Pharmaceuticals has the technical expertise and capability to process and formulate the oils and to use them in its compounding operations. MariJ also has its proprietary Geotraking Technology. This technology is completely compliant with the Health Insurance Portability and Accountability standard (HIPAA), using its “plant to patient” solution.

MariJ Pharmaceuticals and Canna-Cures Research & Development Center, announced in April of 2017 that they successfully completed Phase one of its USDA (United States Department of Agriculture) certified organic processing for Blue Circle Development and organic farm near Ft. Collins, Colorado.

Acacia Diversified Holdings has its Dahlia’s Botanicals product line. Dahlia’s Botanicals sells endocannabinoid nutraceuticals. MariJ is the exclusive organic extraction company and Canna-Cures is the exclusive manufacturer for the Dahlia’s Botanicals line.

In the fall of 2017, Acacia Diversified Holdings, via its wholly-owned subsidiary, Eufloria Medical of Tennessee, Inc., announced that Eufloria secured a processing, manufacturing, and retail sales license(s) in Tennessee. The acquisition of these licenses allows Eufloria Medical of Tennessee to conduct hemp-related business in Tennessee. This is as it moves ahead in this new developing hemp marketplace.

In late November 2017, Acacia Diversified Holdings, via MariJ Pharmaceuticals, announced it received its License to Operate: Manufactured Food Establishment certificate issued on November 8, 2017 by the Colorado Department of Public Health and Environment.

Mr. Richard K. Pertile, the Company’s CEO, said, "We are pleased, for our shareholders and customers of Colorado, to share in these efficiencies surrounding this manufacturing license. This license validates the organic and food grade quality material the Company is able to produce from its mobile extraction labs on beneficial farms in Colorado. This license acquisition sets a new level for the company's mobile fleet, placing it in a new category of quality."

Acacia Diversified Holdings, Inc. (ACCA), closed Monday's trading session at $0.70, down 2.91%, on 4,415 volume with 4 trades. The average volume for the last 60 days is 12,279 and the stock's 52-week low/high is $0.1066/$2.00.

CV Sciences, Inc. (CVSI)

Wealth Insider Alert, Market Intelligence Center Alert, StreetAuthority Daily, Wall Street Mover, Damn Good Penny Picks, OTCtipReporter, Penny Picks, PennyStockScholar, Profitable Trader Authority, Promotion Stock Secrets, and Stock Commander reported earlier on CV Sciences, Inc. (CVSI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

CV Sciences, Inc. concentrates on developing and commercializing novel therapeutics employing synthetic Cannabidiol (CBD). A life science company, CV Sciences operates two divisions - Pharmaceuticals and Consumer Products. These divisions are supported by its medical and scientific advisory board, and state-of-the-art production facilities.

The Company formerly went by the name CannaVEST Corp. It changed its corporate name to CV Sciences, Inc. in January of 2016. CV Sciences has main offices and facilities in San Diego, California and Las Vegas, Nevada. Fundamentally, the Company is a top supplier and manufacturer of hemp-derived phytocannabinoids, including CBD oil, and a developer of specialty pharmaceutical therapeutics.

CV Sciences’ Pharmaceutical Division is developing synthetically-formulated cannabidiol-based medicine. It is pursuing the approval of the U.S. Food and Drug Administration (FDA) for drugs with specific indications using cannabidiol as the active pharmaceutical ingredient. The Company has realized promising preclinical results in the development of cannabinoid medicines for the treatment of an assortment of medical conditions.

In December of 2015, CV Sciences acquired CanX, Inc. CanX is a Pre-Clinical drug development company. It is focusing on significant unmet medical needs. CanX’s first drug candidate is CVSI-007. CVSI-007 chewing gum combines CBD and Nicotine. It is patent pending. CVSI-007 is a proprietary chewing gum. It combines synthetic CBD and nicotine to effectively treat smokeless tobacco addiction.

The Company’s Consumer Products Division delivers botanical-based cannabidiol products that enhance quality of life. Each consumer products brand is backed by a formal safety review, an growing body of case reports, and physician’s recommendations.

In addition, CV Sciences manufactures, markets, and sells plant-based CBD products under the PlusCBD brand. This is for an array of market sectors. These include nutraceutical, beauty care, specialty foods, as well as vape.

In November 2017, CV Sciences announced that it was named on Deloitte’s Technology Fast 500™. This is a yearly ranking of the fastest growing companies in the technology, media, telecommunications, life sciences and energy technology sectors in North America.

The Deloitte Technology Fast 500 is based on percentage of revenue growth from fiscal year 2013 to 2016, with CV Sciences increasing by 403 percent during this time. 2017 is CV Sciences’ first year named on the Deloitte's Technology Fast 500™ list.

CV Sciences, Inc. (CVSI), closed Monday's trading session at $0.43, up 3.86%, on 202,600 volume with 126 trades. The average volume for the last 60 days is 764,679 and the stock's 52-week low/high is $0.136/$0.68.

MYM Nutraceuticals, Inc. (MYMMF)

Stockhouse, MarketWatch, InvestorsHub, OTC Markets, Barchart, Investing, and Market News Updates reported on MYM Nutraceuticals, Inc. (MYMMF), and we choose to report on the Company as well, here at the QualityStocks Daily Newsletter.

MYM Nutraceuticals, Inc. centers on acquiring Health Canada licenses to produce and sell high-end organic medicinal cannabis supplements and topical products. The Company is looking to acquire complementary businesses and assets in the technology, nutraceuticals, and CBD sectors. MYM is the sole owner of CBD brands HempMed, Joshua Tree, and Dr. Furbaby. MYM Nutraceuticals is based in Vancouver, British Columbia. The Company’s shares trade on the OTC Markets’ OTCQB.

Dr. Furbaby is the Company’s CBD line of products specifically for pets. HempMed is targeted at the dispensary market. Joshua Tree is targeted for the mainstream health market.

MYM Nutraceuticals is now building three large-scale production facilities in Canada and Australia. These are the Northern Rivers Project; the Weedon Project; and the Laval Project. Upon completion, the total amount of greenhouse growing space will be in excess of 2.7 million square feet.

The Northern Rivers Project (Casino, New South Wales, Australia) is a 1.2 million sq. ft. greenhouse project. The first crop is expected to be planted in Q4 2018. The Northern Rivers Project facility is believed to be the Southern Hemisphere's largest purpose-built greenhouse, designed specifically to produce medical-grade cannabis.

The Weedon Project is in Weedon, Quebec. The Project will include a cannabis museum and a cannabis university for industry training. The Weedon Project has 1.5 million sq. ft. of greenhouse. This month, MYM Nutraceuticals announced that the Municipality of Weedon approved the building permit to start construction on the greenhouse at the Weedon production facility.

The Company received approval and started Phase One construction of the Weedon production facility. The projected date of completion for Phase One construction is the end of Q3 2018.

The Laval Project facility (Laval, Quebec) is 10,000 sq. ft. It will undergo expansion to 26,000 sq. ft. by 2019. The estimation is that the Laval Project will produce sales of $20 million by 2019.

Additionally, MYM Nutraceuticals has its MJT Manufacturing Project (Toronto, Ontario). The 5,000 sq. ft. production facility is a GMP (Good Manufacturing Practice) certified, state-of-the-art extraction lab and production facility dedicated to industrial hemp processing (CBD).

The MYM Australia Project has filed for a Medical Research License in collaboration with Western Sydney University. MYM Nutraceuticals announced in December of 2017 that PUF Ventures Australia (PVA) filed an application with the Australian Office of Drug Control for a medicinal cannabis license and a cannabis research license in collaboration with The National Institute of Complementary Medicine (NICM). NICM is an Australian Health Research Institute based at Western Sydney University in New South Wales.

Last month, MYM Nutraceuticals announced that it completed the asset purchase from Budly Software, Inc., a foremost software company. Budly has developed a smartphone-enabled sales and distribution system connecting medicinal cannabis patients with local dispensary drivers for speedy delivery and monitoring of orders. Utilizing the system, a customer can choose a dispensary, place an order, and then select a driver to deliver it. The customer can subsequently track the order on his or her smartphone and knows exactly when it will arrive.

MYM Nutraceuticals, Inc. (MYMMF), closed Monday's trading session at $1.90, up 4.05%, on 125,432 volume with 140 trades. The average volume for the last 60 days is 500,058 and the stock's 52-week low/high is $0.1296/$4.00.

Relmada Therapeutics, Inc. (RLMD)

Dividend Opportunities, Investopedia, ProfitableTrading, Wallstreetbuzz, Investors Alley, The Observer, PCG Advisory, Streetwise Reports, Penny Stock Bets, StreetAuthority Financial, SmallCap Network, Trade of the Week, and WallstreetsHotteststocks reported on Relmada Therapeutics, Inc. (RLMD), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Relmada Therapeutics, Inc. is a clinical-stage, specialty pharmaceutical company. It focuses on developing novel versions of proven drug products in combination with new chemical entities, which potentially address areas of high unmet medical need in the treatment of pain. The Company has a varied portfolio of lead products at different stages of development. It is developing novel therapies for the treatment of central nervous system (CNS) diseases. Relmada Therapeutics has its corporate office in New York, New York.

The Company’s lead products are d-Methadone (REL-1017), its N-methyl-D-aspartate (NMDA) receptor antagonist for neuropathic pain; topical mepivacaine - MepiGel (REL-1021), its orphan drug designated topical formulation of the local anaesthetic mepivacaine; oral buprenorphine - BuTab (REL-1028), its oral dosage form of the opioid analgesic buprenorphine; and LevoCap ER (REL-1015), its abuse resistant, sustained release dosage form of the opioid analgesic levorphanol.

BuTab (REL-1028) is its investigational, oral formulation of buprenorphine - an opioid that is widely used to treat addiction and chronic pain. The design of BuTab is to be delivered orally and reach safe and effective blood levels of buprenorphine by way of the gastrointestinal route of administration because of its modified release profile.

In April of 2017, Relmada Therapeutics announced that the Food and Drug Administration (FDA) granted Fast Track designation for d-Methadone (REL-1017 dextromethadone), the Company’s novel N-methyl-D-aspartate (NMDA) receptor antagonist in development for the adjunctive treatment of major depressive disorder.

Recently, Relmada Therapeutics announced that the European Patent Office issued a notice of allowance for patent application number 13773543.7 for "D-methadone for the treatment of psychiatric symptoms." This patent provides extensive coverage in Europe for d-Methadone (dextromethadone, REL-1017), a novel N-methyl-D-aspartate (NMDA) receptor antagonist, for the treatment of symptoms associated with a range of psychological and psychiatric disorders. These include depression, anxiety, fatigue, and mood instability.

In addition, Relmada Therapeutics recently announced that it acquired the worldwide rights to develop and market dextromethadone (REL-1017).

Mr. Sergio Traversa, Relmada Therapeutics’ Chief Executive Officer, said, "The clinically proven mechanism of action of dextromethadone shows potential benefits in the treatment of a wide range of CNS diseases and conditions, including rare diseases that represent significant areas of unmet need in healthcare. We believe that this new agreement is the most important transaction for Relmada since its inception, positioning us to target a wide range of development and global marketing opportunities for dextromethadone in the years ahead."

Relmada Therapeutics, Inc. (RLMD), closed Monday's trading session at $0.7001, up 0.26%, on 8,790 volume with 7 trades. The average volume for the last 60 days is 10,996 and the stock's 52-week low/high is $0.612/$1.40.

Integrity Applications, Inc. (IGAP)

OTC Markets Group and SmallCapVoice reported previously on Integrity Applications, Inc. (IGAP), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Integrity Applications, Inc. is the maker of GlucoTrack®. This is a non-invasive device for measuring glucose levels in people with type 2 diabetes and pre-diabetes. GlucoTrack® is a monitoring device that quickly measures and displays an individual's glucose level in about a minute without finger pricking or any pain. GlucoTrack® has received CE Mark and KFDA approvals for type 2 diabetes and pre-diabetes. It is now in the early stages of commercialization in Europe, South Korea, as well as other geographies.

Formed in 2001, Integrity Applications is a Delaware corporation with its head office in Wilmington, Delaware and a research and development (R&D) site in Ashdod, Israel. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Integrity Applications is concentrating on three important initiatives - GlucoTrack Commercialization in Europe; GlucoTrack U.S. FDA (Food and Drug Administration) Approval; and a Product Roadmap. The Company’s initial main emphasis is on the commercialization of GlucoTrack in Europe.

Regarding U.S. FDA Approval, Integrity Applications has been working with regulatory and clinical experts to clarify the best regulatory pathway for the GlucoTrack. Based on feedback from the FDA, the Company plans to follow a de novo 510k pathway. It expects to begin the U.S. study in early to mid-2018, subject to funding and consultation with the Agency.

Concerning the Product Roadmap, Integrity’s intention is to apply its proprietary technology platform to leverage new developments and trends in the marketplace.

GlucoTrack® features a small sensor. This sensor clips to the earlobe and measures the user's glucose level utilizing innovative and patented sensor technology. The measured signals undergo analysis employing a proprietary algorithm and then a calculated glucose level is displayed on a small handheld device the size of a small mobile phone.

The glucose results are stored in the device and used to project an estimated HbA1c level utilizing a proprietary algorithm. Furthermore, the device can display glucose values graphically, enabling the user to monitor glucose levels over time. GlucoTrack® is currently experimental in the United States. It is limited to investigational use only.

In late December 2017, Integrity Applications announced that it entered into an exclusive distribution agreement with MediReva B.V. for the GlucoTrack® in the Netherlands. MediReva is a family owned business. It comprises a group of companies centered on home healthcare and the distribution of specialty medical products with wide-ranging experience with blood glucose monitoring and diabetes care. The agreement became effective on December 22, 2017.

The Netherlands represents a vital first market for the creation of a scalable blueprint to be used in other European markets where there are about 58 million people living with diabetes. This represents roughly 8.8 percent of the adult population.

Integrity Applications, Inc. (IGAP), closed Monday's trading session at $1.80, even for the day. The average volume for the last 60 days is 3,412 and the stock's 52-week low/high is $1.00/$6.00.

CIB Marine Bancshares, Inc. (CIBH)

Stock Traders Chat and MarketWatch reported earlier on CIB Marine Bancshares, Inc. (CIBH), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

CIB Marine Bancshares, Inc. operates as the bank holding company for CIBM Bank. The Bank provides banking and related services for small and middle-market business customers. Incorporated in 1985, CIB Marine Bancshares lists on the OTC Markets Group’s OTCQB.

CIB Marine Bancshares has its headquarters in Waukesha, Wisconsin. In addition, the Bank has offices in Central and Northeastern Illinois, Milwaukee, as well as Indianapolis markets.

CIB operates via Banking and Mortgage Banking segments. It accepts demand, savings, and time deposits.

The traditional banking services that CIBM Bank provides include a wide spectrum of loan products. These include commercial loans, commercial real estate loans, commercial and residential construction loans, one-to-four family residential real estate loans, consumer loans, and commercial and standby letters of credit.

Furthermore, services provided include acceptance of demand, savings and time deposits; commercial paper and repurchase agreements, and other banking services.

CIBM Bank operates as Marine Bank in its Indiana and Wisconsin markets, Central Illinois Bank in its central Illinois market, and Avenue Bank in its Chicagoland market. Located in Naperville, Illinois, the Avenue Mortgage division of the Bank serves all CIBM Bank markets.

At the end of January 2018, CIB Marine Bancshares announced its unaudited results of operations and financial condition for Q4 and year-end 2017. During Q4 2017, CIB Marine made special tax adjustment entries related to its deferred tax assets. This included a partial reversal of its valuation allowance.

Consequently, CIB reported Net Income after tax of $23.9 million for Q4 2017 and $27.0 million for the year 2017. Pre-tax Net Income for Q4 2017 was $1.2 million or $0.07 basic and $0.03 diluted Earnings per Share, versus $1.1 million for the same period of 2016 and $0.06 basic and $0.03 diluted Earnings per Share.

Pre-tax Net Income for the year ended December 31, 2017, was $4.3 million or $0.24 basic and $0.12 diluted Earnings per Share, versus $4.1 million or $0.23 basic and $0.12 diluted Earnings per Share for the same period of 2016.

CIB Marine Bancshares, Inc. (CIBH), closed Monday's trading session at $1.99, even for the day. The average volume for the last 60 days is 3,381 and the stock's 52-week low/high is $1.00/$1.99.

graphic

The QualityStocks
Company Corner

graphic
graphic

Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF)

The QualityStocks Daily Newsletter would like to spotlight Choom Holdings Inc. (CHOOF). Today, Choom Holdings Inc. closed trading at $0.8168, up 16.67%, on 612,063 volume with 383 trades. The stock’s average daily volume over the past 60 days is 70,076, and its 52-week low/high is $0.125/$0.8612.

Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) is pleased to announce that the Company has entered into a definitive amalgamation agreement, effective March 16, 2018, among itself, its wholly-owned subsidiary, Arbutus Brands Inc., and International Tungsten Inc. Also today, CannabisNewsWire released a report on the company detailing how CHOOF is focused on the recreational marijuana market in Canada and is projecting revenues from its retrofit and expansion efforts in Vernon and Vancouver Island, British Columbia, Canada. In its investor presentation of March 2018 (http://cnw.fm/pER7I), the company positioned itself to become a branded, fully integrated cannabis company in the recreational marijuana market of Canada.

Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s "Choom Gang," a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with "choom," the local's term for marijuana. Choom's trademark slogans pivot off another unconventional phrase ("Say Hello to…"), bringing a heady dose of good times and good friends together as the company invites investors to "Say Hello to Choom™" as it lights up the adult recreational cannabis market in Canada.

Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company's first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom's initial license applications to ensure the company's readiness for legalization of recreational marijuana in Canada mid-summer 2018.

True to the company's character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1's revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.

Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic "Aloha" vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.

A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.

While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company's growth strategy. Get ready to "Say Hello" to opportunity, good times and good friends with Choom™. Disclaimer

Choom Holdings Inc. Company Blog

Choom Holdings Inc. News:

Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Seeking its Share in the Anticipated Canadian Recreational Marijuana Market

Choom™ Signs Definitive Amalgamation Agreement to Acquire Late Stage ACMPR Applicant with Affirmation of Readiness Evidence Package Submitted to Health Canada

CannabisNewsAudio Announces Audio Press Release (APR) on Choom Holdings Inc. Brands Spell Opportunity in Canadian Cannabis Market

Petroteq Energy Inc. (TSX.V:PQE) (OTCQX:PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF). Today, Petroteq Energy Inc. closed trading at $1.22, even for the day, on 103,896 volume with 194 trades. The stock’s average daily volume over the past 60 days is 126,135, and its 52-week low/high is $0.015/$1.8892.

With its patented and proprietary technologies that produce zero greenhouse gas and zero waste, Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) established itself as a pioneer in the environmentally safe extraction of heavy oils from oil sands and oil shale deposits.

Petroteq Energy Inc. (TSX.V: PQE) (OTCQB: PQEFF), with headquarters in Canada, seeks to create the world's largest pure-play cobalt exploration and development company. The company's current focus is on its Greater Cobalt Project located in Silver Centre, Ontario. The company is also in the midst of a three-way merger with Cobalt One Ltd. and CobalTech Mining Inc. and on completion First Cobalt will control over 10,000 hectares of prospective land and 50 historic mining operations in the Cobalt Camp in Ontario, Canada, as well as a mill and a permitted refinery facility.

The merger agreements with Cobalt One Ltd. and CobalTech Mining Inc., announced earlier this year, will result in a combined land position of more than 10,000 hectares (nearly 25,000 acres) in the Cobalt Camp containing approximately 50 past cobalt/silver producers and working mines. Initial test results from a mineralogical assessment of sample material taken from various historical mines located throughout the Cobalt Camp show both cobalt-rich and silver-rich mineralization styles. Samples taken at the former Bellellen mine, located within the Greater Cobalt Project in Ontario, show high grade cobalt assays, prompting First Cobalt to increase its drilling program at that site.

Petroteq Energy Inc. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world's current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

The company's clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, Petroteq Energy Inc. and its mining interests are primed for success.

Petroteq Energy Inc. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance. Disclaimer

Petroteq Energy Inc. Company Blog

Petroteq Energy Inc. News:

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) Creating Value with Disruptive Blockchain Initiative

Petroteq Announces PetroBLOQ's Proposed International Expansion Into Key Strategic Markets

Petroteq's PetroBLOQ Announces Capabilities of Blockchain Based Oil & Gas Supply Chain Management Platform

First Cobalt Corp. (TSX.V:FCC) (OTCQB:FTSSF)

The QualityStocks Daily Newsletter would like to spotlight First Cobalt Corp. (FTSSF). Today, First Cobalt Corp. closed trading at $0.865, up 1.76%, on 166,699 volume with 155 trades. The stock’s average daily volume over the past 60 days is 291,560, and its 52-week low/high is $0.3148/$1.3041.

Cobalt exploration and development company First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF) recently announced that it had started drilling in Cobalt North. The program is centered on the historic Drummond, Kerr and Conisil mines within the Cobalt Camp mining region of northern Ontario. To view the full article, visit: http://nnw.fm/Vi3n2.

First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF), with headquarters in Canada, is the largest land owner in the Cobalt Camp in Ontario with control of over 10,000 hectares (nearly 25,000 acres) of prospective land and 50 historic cobalt/silver mines. The company’s assets include a mill and the only permitted cobalt extraction refinery in North America capable of producing battery material, providing an integrated solution for cobalt projects. First Cobalt began drilling in the historic Cobalt Camp in 2017 and seeks to build shareholder value through new discovery and growth opportunities.

First Cobalt’s 2018 $C7 million drilling program, which includes testing different styles of mineralized areas throughout the Cobalt Camp in more than 10 past-producing mines known to contain cobalt, is a significant expansion over its 2017 exploration activities. The company received positive test drill results from the Bellellen mine location, with early results confirming the presence of high-grade cobalt and nickel, prompting First Cobalt to increase its drilling program at that site. A prospecting sampling program of existing muckpiles around the camp’s historic mines, trenches, pits and surrounding bedrock could provide an early production scenario.

First Cobalt Corp. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world’s current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.

First Cobalt is embracing innovation in the mining sector, utilizing a digital compilation of 100-plus years of mining and geological data spanning the historically prolific Cobalt Mining Camp’s lifespan. First Cobalt’s management team is also assessing the ability of artificial intelligence to accelerate the discovery cycle. As a member of the Mineral Exploration Research Centre (MERC) and Metal Earth Project, First Cobalt conducts regional geophysical surveys for geological interpretation of structures controlling cobalt-silver mineralization.

The company’s clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, First Cobalt Corp. and its mining interests are primed for success.

First Cobalt Corp. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance. Disclaimer

First Cobalt Corp. Company Blog

First Cobalt Corp. News:

NetworkNewsBreaks – First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF) Targets Historically-producing Mines in Cobalt North

First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF) Turns Canadian Property into Global Trendsetter in Smart, Ethical Mining

First Cobalt Announces Friendly Acquisition of US Cobalt

ABcann Global (TSX.V:ABCN) (OTCQB:ABCCF)

The QualityStocks Daily Newsletter would like to spotlight ABcann Global (ABCCF). Today, ABcann Global closed trading at $1.70, even for the day, on 164,394 volume with 257 trades. The stock’s average daily volume over the past 60 days is 766,702 and its 52-week low/high is $0.6171/$3.2929.

Choom and ABcann Global Corporation (TSXV: ABCN, OTCQB: ABCCF) are pleased to announce that the Company has completed a financing of subscription receipts (each, a "Subscription Receipt") for gross proceeds of $7.0 million including a $4.0 million lead order from ABcann.

ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF) ABcann Medicinals, Inc. is a globally licensed, cost efficient producer of premium quality organic standardized medicinal cannabis. One of the earliest licensed Canadian medical marijuana producers under Canada's federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), ABcann has five years of operating experience in the burgeoning medical marijuana space. The company currently owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario. Additionally, ABcann owns 65 acres of real estate with proper zoning and existing infrastructure in place to support the construction of another production facility of up to one million square feet.

In a November 2016 report, market research firm Canaccord Genuity Group forecasted that the medical marijuana market in Canada could see sales in excess of $8 billion by 2024, creating a sizable opportunity for the country's licensed producers (LPs). The research firm also noted that the "rigorous process of becoming a licensed producer of cannabis in Canada imposes significant barriers to entry and there will be a shortfall of supply in a legalized market in the short-term." This market barrier serves as a strategic advantage for ABcann as it prepares for its highly-anticipated IPO, which is currently scheduled for April 2017.

Canaccord's synopsis of the Canadian cannabis industry is supported by recent market activity, as companies sporting one of the illustrious Canadian government licenses for medicinal production have recorded strong growth following IPO. Canopy Growth (OTC: TWMJ), one of the largest fully-licensed Canadian marijuana growers, saw share prices skyrocket by more than 700 percent in the months following its initial offering. Aphria Inc. (OTC: APHQF), another licensed grower, climbed by more than 900 percent following its IPO. Other companies that have recorded huge growth since going public include Aurora Cannabis (OTC: ACBFF), climbing nearly 900 percent, and SupremePharma (OTC: SPRWF), which soared more than 1,300 percent.

With these market trends in mind, ABcann's impending IPO is one that prospective investors in the marijuana sector will want to explore. Recalls from some of the biggest players in the Canadian cannabis industry have highlighted the considerable learning curve that LPs face in today's market, which makes ABcann's proven track record in the market all the more noteworthy. The company has built a reputation over the years for its best-in-class standardized approach to growing cannabis, including the thoughtful omission of pesticides and a computer monitored growing technique that allows ABcann to minimize the risks of variance in its yields and ensure the creation of consistently high-quality products.

This technique, which the company calls the ABcann Advantage, has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with ABcann's current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry. This global growth potential is illustrated by ABcann's partnership with Israel's Syqe Medical, producer of the world's first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting the company's production facility, Perry Davidson, founder of Syqe Medical, noted that ABcann's production technologies put it "in a class with the best in the world" in its ability to produce standardized pharmaceutical grade cannabis.

ABcann's entry into the public sector is being guided by a seasoned management team, board of directors and advisory board that feature well over a century of combined industry experience. Ken Clement, the company' founder and executive chairman, has been the key component and driving force behind ABcann's development since its inception. His vision of standardized production and dosage sets ABcann apart in the medical cannabis sector. Clement is joined on the company's management team by CEO Aaron Keay. Keay brings more than a decade of capital markets experience to ABcann, having played a role in raising approximately $250 million for public and private market issuers.

Notably, ABcann also has access to the 'Father of Cannabis Research', Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC), and he has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, ABcann is well-positioned to compete in the rapidly-expanding Canadian medicinal cannabis industry. These factors, along with the company's ongoing global expansion into the European, Australian and Israeli markets, show why ABcann Medicinals' upcoming public offering fits the bill as "Canada's Next Medical Marijuana IPO." Disclaimer

ABcann Global Blog

ABcann Global News:

Choom™ and ABcann Announce Strategic Investment and Supply Agreement

ABCann Announces Resignation of Founding Director Ken Clement

Preventive Medical Solutions Integrate with Major Cannabis Providers for Innovative Drug Delivery

IEG Holdings Corp. (IEGH)

The QualityStocks Daily Newsletter would like to spotlight IEG Holdings Corp. (IEGH). Today, IEG Holdings Corp. closed trading at $0.26615, even for the day. The stock’s average daily volume over the past 60 days is 89,735 and its 52-week low/high is $0.14/$4.19.

Consumer loan provider IEG Holdings Corp.’s (OTCQB: IEGH) chairman, chief executive officer, sole director and largest shareholder, Paul Mathieson, wholly-owns Investment Evolution Coin Ltd. (“IEC Ltd.”), which has entered a partnership with California-based blockchain company, HashCash Consultants. To view the full press release, visit: http://nnw.fm/Mwi9p.

IEG Holdings Corp. (IEGH) is a publicly traded, global leader in consumer finance providing small-sized online personal loans in the United States via a state-licensed operating subsidiary, Investment Evolution Corporation, under the consumer brand "Mr. Amazing Loans." Based in Las Vegas, the company originates consumer loans in 20 states: Alabama, Arizona, California, Florida, Georgia, Illinois, Kentucky, Louisiana, Maryland, Missouri, Nevada, New Jersey, New Mexico, Ohio, Oregon, Pennsylvania, Texas, Utah, Virginia and Wisconsin via its online platform and distribution network. IEGH is a licensed direct lender with state licenses and/or certificates of authority to lend in each state and offers all loans within the prevailing statutory rates.

Mr. Amazing Loans is a leading FinTech company specializing in dedicated loan amounts of $5,000 to $10,000 offered directly to consumers through an easy-to-use website known for its professional interaction with applicants. All loans are originated, processed and serviced out of the company's Las Vegas corporate offices, eliminating the need for physical locations in each state where IEGH is licensed to conduct business. The company's loans are unsecured consumer loans that mature in five years at interest rates significantly less than those of payday lenders. Consumers are able to receive same-day processing and are assured of no hidden or additional fees, no prepayment penalty, with repayment and interest rates fixed at 29.9% or less Annual Percentage Rate (APR) for the life of the loan.

The Center for Responsible Lending states the typical payday loan has rates ranging from 391% to 521% APR on loans that typically range from $100 to $1,000. Conversely, Mr. Amazing Loans's terms are designed with low fixed repayments to fit into consumer budgets with the added goal of helping clients reach a stronger financial position. Loan funds are deposited directly into an approved consumer's checking account and may be approved the same day after necessary application documentation is received.

IEG Holdings has also incorporated Investment Evolution Crypto, LLC., a 100 percent owned subsidiary, and tasked the new company with exploring business opportunities in the cryptocurrency/blockchain industry. Specifically, the subsidiary company will explore the legalities and economic risks of entering into a joint venture with IEGH's other 100 percent owned subsidiary company, Investment Evolution Corporation dba Mr. Amazing Loans. Among the questions to be answered during this development planning stage are whether Mr. Amazing Loans should accept repayment of customer loans in the form of leading crypto/blockchain currencies such as Bitcoin, provide the equivalent of USD $5,000 and $10,000 loans to consumers in cryptocurrencies, and potentially create and issue an Investment Evolution cryptocurrency.

Paul Mathieson, IEG Holdings' chairman and Chief Executive Officer, has over 19 years of finance industry experience in lending, funds management, stock market research and investment banking. He has been a member of the board of directors at IEGH since 2012 and of its subsidiary since 2009. Mathieson founded IEG Holdings Limited in Sydney, Australia, launching the Amazing Loans business in that country in 2005 and then in the United States via IEGC in 2010. He was awarded Ernst & Young's 2007 Australian Young Entrepreneur of the Year (Eastern Region). Mathieson is joined by Carla Cholewinski, who serves as chief operating officer with over 37 years of experience in the finance industry including banking, credit union management, regulatory oversight, debt securitization and underwriting. Disclaimer

IEG Holdings Corp. Blog

IEG Holdings Corp. News:

NetworkNewsBreaks – IEG Holdings Corp.’s (IEGH) CEO’s Wholly-owned IEC Ltd. Partners with HashCash Consultants to Enable Global Remittances

IEG Holdings Announces Distribution by CEO of Investment Evolution Coin Ltd. Shares to IEG Holdings Shareholders and Hold on Cryptocurrency Development

IEG Holdings Corp. (IEGH) Revenues Pegged to Quadruple by 2020

ChineseInvestors.com, Inc. (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com, Inc. (CIIX). Today, ChineseInvestors.com, Inc. closed trading at $0.578, off by 2.50%, on 74,811 volume with 54 trades. The stock’s average daily volume over the past 60 days is 93,822 and its 52-week low/high is $0.40/$1.58.

ChineseInvestors.com, Inc. (OTCQB: CIIX), the premier financial information website for Chinese-speaking investors, today announces that it is exploring investments into Cryptocurrency Mining with its recent purchase of ASIC (Application Specific Integrated Circuit) machines used to mine SHA-256 or Scrypt mining algorithms to earn cryptocurrencies such as Bitcoin and Litecoin. 

Founded in 1999, ChineseInvestors.com, Inc. (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world's first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer's disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX's cannabis-focused "Yelp"-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide. Disclaimer

ChineseInvestors.com, Inc. Blog

ChineseInvestors.com, Inc. News

ChineseInvestors.com, Inc. Explores Investments Into Cryptocurrency Mining Through Testing of ASIC (Application Specific Integrated Circuit) Machines With Plans to Expand Its Mining Operations in the Near Future

ChineseInvestors.com, Inc. (CIIX) CEO Discusses the Company’s Future on MoneyTV

ChineseInvestors.com Discusses Spin Out of Their Hemp Division and Focus on Cryptocurrency Market in China With WSA

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H)

The QualityStocks Daily Newsletter would like to spotlight PreveCeutical Medical Inc. (PRVCF). Today, PreveCeutical Medical Inc. closed trading at $0.3271, off by 2.12%, on 18,062 volume with 11 trades. The stock’s average daily volume over the past 60 days is 21,689, and its 52-week low/high is $0.01/$0.80.

PreveCeutical Medical Inc. (CSE: PREV, OTCQB: PRVCF, FSE: 18H), Chairman and CEO Stephen Van Deventer, was recently interviewed on Uptick Newswire’s “Stock Day” podcast with Mr. Everett Jolly.

PreveCeutical Medical Inc. (PRVCF), headquartered in Vancouver, British Columbia, Canada, is a health sciences company dedicated to researching and developing innovative options for preventive and curative therapies utilizing organic and Nature Identical™ products. The company is strategically staking out select positions in the medically acute areas of diabetes and obesity, pain management, neurological disorders and cancer.

PreveCeutical Medical Inc. had its beginnings in 2009 when Stephen Van Deventer, a seasoned businessman and venture capitalist, and Kimberly Van Deventer, a successful entrepreneur, met and formed a business partnership. The duo created Cornerstone Global Partners, a venture capital and business development company, and became involved in numerous ventures including building companies such as Aurora Cannabis Inc. Taking their interest in the health and wellness market further, the pair began researching how nature and science can work together to benefit health-conscious consumers. Coining and trademarking the word "PreveCeutical" – a combination of the words "preventive" and "pharmaceutical" – was a precursor to the company's formation and incorporation in October 2015.

The company's first product was developed in the Dominican Republic and is now marketed and distributed worldwide by PreveCeutical. It is a Caribbean Blue Scorpion venom product sold under the trade name CELLB9®. This product is an oral dilute solution infused with select peptides sourced exclusively from the blue scorpion (Rhopalurus princeps) found only in Caribbean nations. The active potentiated ingredients in CELLB9, which have been used in over 40 countries for over a decade, appear to support health at a deep, cellular level. PreveCeutical's research team is using proprietary chemistry to generate Nature Identical™ peptides derived from natural compounds found in Caribbean Blue Scorpion venom with the goal of eventually treating, regulating and preventing cancer progression. Peptides are also being used to target an array of disease indications including metabolic disorders, pain management, cancers, cardiovascular and infectious diseases.

PreveCeutical is developing the first nose-to-brain delivery system of cannabinoids (CBDs) with a novel process that prepares insoluble drug-containing nano-micelles and successfully incorporating them into a proprietary sol-gels application, essentially creating a targeted drug delivery vehicle. Intended for use via a nasal spray, this unique formulation rapidly gels upon contact with mucosal tissue, which paves the way for direct nose-to-brain delivery. This novel application eliminates first pass metabolism (stomach, intestines, liver), potentially improving bioavailability and delivering extended time release formulations that may alleviate side effects of higher dosage therapeutics. This CBD-based patented formula is projected to be deployed in selected markets with licensed medical marijuana companies within 18 months.

PreveCeutical is working with four leading Australian research centers to develop a curative therapy for diabetes and obesity. This four-year program involves engineering a novel approach that selectively targets the gene that encodes for the protein PTP-1B, which is implicated and over-expressed in both type-2 diabetes and obesity. PreveCeutical's gene-silencing technology would effectively "turn off" the genetic signal which leads to the over-production of this key protein molecule, bringing it back down to safe, normalized levels, and prevent the body from storing excessive fat. Diabetes kills one person every six seconds, with more than $800 billion spent globally on the disease.

Another exciting joint venture, established with Sports 1 Marketing, will focus on the therapeutic potential in the peptides and proteins connected to the Caribbean Blue Scorpion venom to potentially treat mild brain injury concussions. Developing a therapeutic product geared towards athletes who suffer from concussions could help alleviate suffering experienced by those who are affected by head trauma.

PreveCeutical Medical's science and research team is led by Dr. Harendra (Harry) Parekh, Ph.D., who is based at the University of Queensland's (UQ) Pharmacy Australia Centre of Excellence (PACE), and Dr. Makarand Jawadekar, Ph.D., whose 28 years of R&D experience with Pfizer Inc., is applicable in his role as chief science officer. Research collaborators include Dr. Rakesh Veedu, an emerging expert internationally in the field of molecular medicine, and Professor Grant Ramm, who is currently head of a leading medical research institute located in Brisbane, Australia.

PreveCeutical Medical is partnering with leading industry experts and companies in its quest to be a leader in the preventive health sciences sector. Its Research and Development partnership with UniQuest, the main commercialization company for the University of Queensland, provides PreveCeutical with the rights to all intellectual property arising from projects created under the agreement. PreveCeutical Medical Inc.'s management team brings an extensive portfolio of research experience, product development, deep corporate strategy and capital markets leadership to the company's core. Disclaimer

PreveCeutical Medical Inc. Company Blog

PreveCeutical Medical Inc. News:

Uptick Newswire’s “Stock Day” Podcast Hosts Stephen Van Deventer, Chairman and CEO of PreveCeutical Medical Inc.

NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Incorporates Australian Subsidiary

NetworkNewsAudio Announces Audio Press Release (APR) on PreveCeutical Medical Inc. Making Bold Advances in Preventative Medicine

Marijuana Company of America Inc. (MCOA)

The QualityStocks Daily Newsletter would like to spotlight Marijuana Company of America Inc. (MCOA). Today, Marijuana Company of America Inc. closed trading at $0.028, off by 4.73%, on 5,237,554 volume with 259 trades. The stock’s average daily volume over the past 60 days is 13,263,846 and its 52-week low/high is $0.0181/$0.0728.

In spite of all of the short-term political gyrations, the cannabis and hemp markets continue to bloom. The demand for cannabidiol (CBD) products remains persistent, and there are many attractive opportunities in the sector. Marijuana Company of America, Inc. (OTC: MCOA) is in position to thrive in spite of any short-term contortions in the cannabis and hemp markets.

Marijuana Company of America Inc. (MCOA) (the "Company") are pioneers in the cannabis industry going back to 2009 when Don Steinberg, MCOA's CEO, founded the first marijuana company ever to trade on a US stock market, Medical Marijuana Inc. Since then, Don and his partner, Charlie Larsen, have formed Global Hemp Group and Marijuana Company of America. They have experienced the shift of legislation first hand, not only for the legalization of marijuana but also the emerging hemp-based CBD products.

The CBD market is growing expotentially and consequently the founders of MCOA have contructed their business model around the development of industrial hemp-based CBD products. The industrial hemp plant can also be used to produce products that are carbon neutral or even carbon negative, like the longest, strongest natural fiber on earth, building materials that are mold, pest and fire proof, super foods and so much more for additional business opportunities. No part of the plant is left unused and the Company's overall stategy is to take advantage of every profit center from farm to the multiple valuable finished products.

The cannabis and hemp industries are experiencing unprecedented exponential growth that is expected to continue for many years as these industries are now accepted globally and continue to mature and expand. North American consumers spent $6.7 billion on legal cannabis products in 2016, up 34% from 2015's $5 billion. This trend is widely expected to explode at a 27% compounded annual growth rate to reach $22.6 billion by 2021, according to ArcView Market Research.

The company offers investors the opportunity to be on the forefront of cannabis and hemp innovation through cultivation, processing in the legal and cannabis and industrial hemp sectors. The Company's business model includes producing a diverse portfolio of synergistic business segments that provide value to its shareholders. Its vertically integrated business model and distribution platforms are positioned to capture market share by developing recognizable and valuable brands.

Under the MCOA umbrella, wholly owned subsidiary hempSMART™, Inc. is committed to bringing high quality CBD-based products to the market through its affiliate marketing program. Through hempSMART, MCOA's strategic approach to the distribution of products is through a networking architecture geared to maintain customer loyalty and capture market share. The patent-pending product "hempSMART Brain," is designed to revolutionize the safe and effective support of healthy brain function. The brand new product, HempSMART DROPS, is a full-spectrum CBD tincture formulated with hemp and fractionated coconut oils. The hempSMART marketing team has decades of experience, and is well positioned to take the hempSMART brand to a global audience. Disclaimer

Marijuana Company of America Inc. Blog

Marijuana Company of America Inc. News:

Marijuana Company of America, Inc. (MCOA) Creating a Diversified Range of Synergistic Opportunities in Hemp Sector

Marijuana Company of America Announces the Offical Launch of Benihemp at the ASD Trade Show

CannabisNewsBreaks – Marijuana Company of America, Inc. (MCOA) Inks New Staffing Contract with Cannabis Strategic Ventures, Inc. (NUGS)

Reign Sapphire Corp. (RGNP)

The QualityStocks Daily Newsletter would like to spotlight Reign Sapphire Corp. (RGNP). Today, Reign Sapphire Corp. closed trading at $0.15, off by 6.25%, on 18,000 volume with 4 trades. The stock’s average daily volume over the past 60 days is 66,228, and its 52-week low/high is $0.0519/$0.325.

Reign Sapphire Corp. (RGNP), a direct-to-consumer custom and branded jewelry company operating jewelry sales, jewelry technology and blockchain divisions, today provided further updates on key features and timeline for Reign Coin, the Company’s sapphire-backed cryptocurrency.

Reign Sapphire Corp. (RGNP), is a direct-to-consumer, custom and branded jewelry company headquartered in Los Angeles, California. Reign's mission is to provide ethical and sustainable jewelry direct to the modern consumer, marketed through sophisticated digital initiatives that speak directly to individuals through social media channels and personalized promotions. The company's lean operating model ensures expenses are linked to order flow with flexible production schedules targeting just-in-time delivery, which in turn reduces or eliminates commodity risk. Reign is a member of the American Gem Trading Association, which is committed to fair trade and processing of gemstones.

Reign Sapphire Corp. owns and operates three divisions: Reign Brands, Reign Ventures and Reign Blockchain. Reign Brands features four unique, niche jewelry brands with separate social media followings:

  • Reign Sapphires: Ethically produced, millennial-targeted sapphire jewelry sourced from Australia.
  • Coordinates Collection: Custom jewelry inscribed with location coordinates commemorating life's special moments.
  • Le Bloc: Classic, customized jewelry.
  • ION Collection by Jen Selter: Athleisure jewelry brand.

Reign Ventures is the company's joint venture platform for investment and development of jewelry technology-related products.

Reign Blockchain authenticates its sapphires as conflict-free, allowing customers to wear products created by a company that shares their beliefs in human dignity and environmental stewardship. In 2018, Reign Blockchain is preparing to conduct an initial coin offering (ICO) for ReignCoin, subject to regulatory approval. ReignCoin will serve as Reign's cryptocurrency as part of a blockchain-based loyalty reward program.

The company's products are sold through a commission-based affiliate program that is supported by personalized email campaigns and promotions, celebrity promotion and gifting, digital advertising based on keyword purchases and sponsored ads, and creative publicity events and media outreach to attract maximum exposure. The successful launch of a company-wide social media influencer campaign across all its retail brands boosted Reign's Instagram, Twitter and Facebook followings by double digits within the first three weeks of going live.

Reign continues to seek out international partnerships, adding to the success it has already achieved in the Middle East, where its flagship store is in the Dubai Mall. The company recently teamed up with the original founder of its Coordinates Collection brand, Owen de Vries, who will lead its Europe and United Kingdom sales efforts. The Netherlands-based operation will proliferate Reign point-of-sales that are adapted for local language, digital marketing and customer service.

Reign Sapphire Corp. is led by president and CEO Joseph Segelman, who has also served on the board of directors since December 2014. Segelman earlier served as the Chief Executive Officer and managing director of Australian Sapphire Corporation, Shefa Mining Corporation and Spencer Lloyd & Associates. He is an experienced marketing and operations professional with over 20 years of experience in logistics and marketing, and extensive experience in the Australian mining and gem industry. He is also a director and board member of OBK (a Sydney, Australia, based charity) and a Captain (Chaplain) in the Australian Army reserves. Segelman is the author of "Take Action: Successful Australians Share their Secrets." (Lothian Books, 2004).

The company's board of advisors includes Andrea Hansen, jewelry marketing veteran and former president of the Women's Jewelry Association; Jeremy Avitan, CPA and compliance executive; Michael Lawrence corporate lawyer and litigator, Doug Cole, corporate financier and entrepreneur, Thierry Chaunu, a luxury goods executive with prior senior management roles at Chopard, Christofle and Cartier, and Pinny Gwinisch, founder of Ice.com and adjunct professor at McGill and Rutgers University. Disclaimer

Reign Sapphire Corp. Company Blog

Reign Sapphire Corp. News:

Reign Sapphire Corp Issues Update on Reign Coin White Paper in Preparation for Launch

Reign Sapphire Corp. (RGNP) Stirs Emotions with Personalized Appeal to Stone-Loving Hearts

Reign Sapphire Corp. Provides Update on Core Business Unit, Discusses Revenue Strategy

Epazz, Inc. (EPAZ)

The QualityStocks Daily Newsletter would like to spotlight Epazz, Inc. (EPAZ). Today, Epazz, Inc. closed trading at $0.1086, off by 3.89%, on 152,053 volume with 36 trades. The stock’s average daily volume over the past 60 days is 393,823, and its 52-week low/high is $0.0045/$0.52.

In May 2017, Epazz (OTC: EPAZ) launched its bitcoin payment solution, ZenaPay. ZenaPay is a cutting-edge technology that makes it significantly easier for users to purchase cryptocurrencies and for vendors to get paid in a secure and reliable system. To view the full article, visit: http://nnw.fm/dmN9G.

Epazz, Inc. (EPAZ), is a leading provider of blockchain cryptocurrency mobile apps and cloud-based business software solutions that specializes in providing customized web applications to the corporate world, higher education institutions and the public sector. The company's strategic expansion into the investment fintech software space can be seen in the recent acquisition of the android app CryptoFolio, which securely tracks and manages Bitcoin and Altcoin portfolios. Epazz, Inc., which acquired the software rights, source code and user base of CryptoFolio, plans to add additional cryptocurrencies and languages to the app, along with an iOS version to attract more users.

Epazz also offers ZenaPay Bitcoin wallet, which has been downloaded more than 10,000 times since its launch on the Play Store. A subsidiary of Epazz, ZenaPay is a financial technology company that offers a unique, secure and reliable Bitcoin payment app, allowing consumers to acquire Bitcoin at the point-of-sale. The consumer can then use this digital currency to make a purchase with ease. The CryptoFolio business model provides free features to attract users and then allows users to purchase additional features from $1.99 to $5.99 each. CryptoFolio is a great add-on app for ZenaPay, and future versions of CryptoFolio will include an option to download ZenaPay.

"We are starting 2018 with ZenaPay on both major mobile apps' platforms," said Shaun Passley, PhD, CEO and founder of Epazz. "We are in the processing of developing new blockchain technology which will introduce an additional source of revenue streams for our company."

Epazz technology makes it easy to convert legacy systems into cloud business process software, for which the company then charges an annual subscription fee. Epazz has acquired 11 software companies that have converted or are in the process of converting their legacy software products to cloud software using Epazz technology. Epazz then markets the new cloud-based solutions to new and existing customers.

Epazz's unique BoxesOS™ applications can create virtual communities for enhanced communication, provide information and content for decision-making, and create a secure marketplace for any type of commerce. Epazz has also filed a provisional patent for its new blockchain smart legal contract technology that reduces fraud in business transactional contracts. The technology allows for a transactional contract to become a living contract that is tracked and traced; it also verifies that a section of terms within a contract are followed and that all parties of an agreement obey the terms of the contract.

"Blockchain-based technology is the future of the Internet," Passley said. "Epazz will add blockchain technology to all of our products in the coming months using our blockchain cloud platform, BoxesOS. The company has been working with customers to understand the best uses of blockchain, and we are excited about filing the first of many blockchain patents, with many more to come." Disclaimer

Epazz, Inc. Company Blog

Epazz, Inc. News:

NetworkNewsBreaks – Epazz, Inc. (EPAZ) Advances Toward Million User Goal for ZenaPay Cryptocurrency Wallet

Epazz Social Media Blockchain Decentralized Platform to Be Released on June 30

Epazz, Inc. (EPAZ) Challenges Status Quo with ZenaPay Cryptocurrency Wallet

graphic

Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters

graphic

1.

Monster Alerts
(ASZP) +113.33%

2.

StreetInsider
(KLDX) +52.78%

3.

QualityStocks
(AVOP) +31.58%

graphic
By The Numbers Charts
QualitystockTwits

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors
















 

The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

 

About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251